
 


Draft Agenda For Tomorrow's T'con - Provenge, November 5, 2009


 
From:              Bross, Peter F (CBER)
To:                 "Smith, Liz"; Tull, Lori;
cc:                 George, Bindu;
Subject:          Draft Agenda for tomorrow"s T"con
Date:              Thursday, November 05, 2009 6:40:04 PM
Attachments:    Dendreon Questions11-6-09 (4).doc
 


 Liz:

Sorry I got these out too late for Lori to send to you today. Due to the time 
zone I thought I would send you an agenda tonight in case it would be helpful 
for planning. In the future I will try to convey all agendas and other materials 
through Lori.

We do not expect you to work late tonight and try to get responses to these 
questions by tomorrow. If you can direct us to the BLA submission for answers 
that would be helpful otherwise we will plan to clarify any of these questions 
which you don't understand and schedule a followup T'con to discuss your 
responses.

Thanks,

Peter F. Bross, MD
Medical Review Officer
Office of Cellular, Tissue, and Gene Therapy, HFM-755
Center for Biologics Evaluation and Research
Food and Drug Administration
1401 Rockville Pike, Rockville, MD 20852
Phone 301 827 5142
Fax 301 827 979
Peter.Bross@fda.hhs.gov

THIS MESSAGE IS INTENDED ONLY FOR THE USE OF THE PARTY TO WHOM IT IS ADDRESSED 
AND MAY CONTAIN INFORMATION THAT IS PRIVILEGED, CONFIDENTIAL, AND PROTECTED FROM 
DISCLOSURE UNDER LAW. If you are not the addressee, or a person authorized to 
deliver the document to the addressee, you are hereby notified that any review, 
disclosure, dissemination, copying, or other action based on the content of this 
communication is not authorized. If you have received this document in error, 
please immediately notify the sender immediately by e-mail or phone.


From: Smith, Liz [mailto:lsmith@Dendreon.com]
Sent: Friday, October 30, 2009 5:58 PM
To: Bross, Peter F (CBER); Tull, Lori
Subject: Agenda for Friday

Hi Peter and Lori,

We are confirmed for a telecom on Friday 11/6 at 2 pm EST. The conference number 
is 888-924-9240, code (b)(2).

We will have clinical, regulatory and biometrics participating (including Brent 
Blumenstein). Do you have specific agenda items or questions that you know you 
want to cover?

Talk to you on Friday. Have a nice weekend.

Best,

Liz

 


********************************************
Elizabeth C. Smith
Vice President of Regulatory Affairs
Dendreon Corporation
3005 First Ave
Seattle, WA 98121
t: 206.829.1556/ f: 206.219.1004/ m. 206.719.4366
esmith@dendreon.com
*******************************************

 


This email message including any attachments is for the sole use of the intended 
recipient(s) and may contain confidential and privileged information. Any 
unauthorized review, use, disclosure or distribution is prohibited. If you are 
not the intended recipient, please contact the sender by reply email and destroy 
all copies of the original message. If you are the intended recipient, please be 
advised that the content of this message is subject to access, review and 
disclosure by the sender's Email System Administrator.
 
